Veracyte (VCYT) Profit Margin (2012 - 2026)
Veracyte (VCYT) profit margin from Sep 30, 2012 to Mar 31, 2026. The current Veracyte (VCYT) profit margin is 20.64%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Profit Margin
Quarterly Profit Margin
Annual Profit Margin change of Veracyte (VCYT)
| Year | Profit Margin | Change |
|---|---|---|
| 2025 | 12.83% | +136.91% |
| 2024 | 5.42% | -126.28% |
| 2023 | -20.61% | +67.14% |
| 2022 | -12.33% | -64.18% |
| 2021 | -34.42% | +15.84% |
| 2020 | -29.72% | +183.88% |
| 2019 | -10.47% | +344.09% |
| 2019 | -2.36% | -71.47% |
| 2019 | -8.26% | +27.06% |
| 2019 | -6.50% | -73.99% |
| 2018 | -25.00% | +31.25% |
| 2018 | -19.05% | -30.67% |
| 2018 | -27.47% | -40.03% |
| 2018 | -45.81% | +6.32% |
| 2017 | -43.09% | +7.07% |
| 2017 | -40.24% | +1.48% |
| 2017 | -39.65% | -20.74% |
| 2017 | -50.03% | +3.83% |
| 2016 | -48.19% | +58.91% |
| 2016 | -30.32% | -60.40% |
| 2016 | -76.57% | +3.03% |
| 2016 | -74.32% | +9.16% |
| 2015 | -68.08% | -6.03% |
| 2015 | -72.45% | -5.60% |
| 2015 | -76.74% | +13.15% |
| 2015 | -67.83% | -11.81% |
| 2014 | -76.90% | -4.21% |
| 2014 | -80.28% | +4.79% |
| 2014 | -76.61% | -14.08% |
| 2014 | -89.17% | +231.25% |
| 2013 | -26.92% | -76.11% |
| 2013 | -112.70% | -11.96% |
| 2013 | -128.01% | -18.62% |
| 2013 | -157.31% | +277.99% |
| 2012 | -41.62% | -72.87% |
| 2012 | -153.42% | -17.82% |
| 2012 | -186.69% | -35.43% |
| 2012 | -289.12% | -46.94% |
| 2011 | -544.91% | N/A |
Comparison Veracyte (VCYT) profit margin with competitors
Veracyte (VCYT) profit margin is 20.64%.
| Ticker | Name | Profit Margin | Upside |
|---|---|---|---|
| IDXX | Idexx Laboratories Inc | 24.41% | +18.24% |
| QGEN | Qiagen NV | 20.33% | -1.52% |
| MTD | Mettler-Toledo International Inc | 17.89% | -13.34% |
| MEDP | Medpace Holdings Inc | 17.53% | -15.09% |
| DHR | Danaher Corp | 17.29% | -16.25% |
| A | Agilent Technologies Inc | 16.96% | -17.85% |
| BLLN | Billiontoone Inc - Class A | 16.58% | -19.69% |
| TMO | Thermo Fisher Scientific Inc | 15.00% | -27.34% |
| ILMN | Illumina Inc | 12.28% | -40.52% |
| SHC | Sotera Health Company | 9.49% | -54.03% |
| DGX | Quest Diagnostics Inc | 8.70% | -57.86% |
| LH | Laboratory Corp Of America Holdings | 7.85% | -61.97% |
| IQV | IQVIA Holdings Inc | 6.60% | -68.03% |
| FONR | Fonar Corp | 6.20% | -69.97% |
| RVTY | Revvity Inc | 5.73% | -72.24% |
| ICLR | Icon Plc | 2.78% | -86.53% |
| CDNA | Caredx Inc | 2.39% | -88.42% |